BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24394986)

  • 21. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
    Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J
    Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy
    Li Y; Ma FH; Xue LY; Tian YT
    World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of key genes and pathways in gastric signet ring cell carcinoma based on transcriptome analysis.
    Zhao ZT; Li Y; Yuan HY; Ma FH; Song YM; Tian YT
    World J Clin Cases; 2020 Feb; 8(4):658-669. PubMed ID: 32149050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
    Lemoine N; Adenis A; Bouche O; Duhamel A; Heurgue A; Leteurtre E; Amela E; Salleron J; Hebbar M
    Anticancer Res; 2016 Oct; 36(10):5543-5549. PubMed ID: 27798928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is signet-ring cell carcinoma a specific entity among gastric cancers?
    Voron T; Messager M; Duhamel A; Lefevre J; Mabrut JY; Goere D; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C; Paye F
    Gastric Cancer; 2016 Oct; 19(4):1027-1040. PubMed ID: 26606931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features.
    Zhao W; Jia Y; Sun G; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xing L; Chai J
    Nat Commun; 2023 May; 14(1):2985. PubMed ID: 37225691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management.
    Drubay V; Nuytens F; Renaud F; Adenis A; Eveno C; Piessen G
    World J Gastrointest Oncol; 2022 Aug; 14(8):1406-1428. PubMed ID: 36160745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological Features and Prognostic-Related Risk Factors of Gastric Signet Ring Cell Carcinoma: A Meta-Analysis.
    Guo Y; Wang Q; Tian Q; Bo C; Li N; Zhang S; Li P
    Comput Math Methods Med; 2022; 2022():3473445. PubMed ID: 36035278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
    Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
    World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prognostic Significance and Gene Expression Characteristics of Gastric Signet-Ring Cell Carcinoma: A Study Based on the SEER and TCGA Databases.
    Ma J; Meng Y; Zhou X; Guo L; Fu W
    Front Surg; 2022; 9():819018. PubMed ID: 35372476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomic Subsites and Prognosis of Gastric Signet Ring Cell Carcinoma: A SEER Population-Based 1 : 1 Propensity-Matched Study.
    Xie Y; Song X; Dong W; Jin H; Ni Z; Li X; Huang H
    Biomed Res Int; 2022; 2022():1565207. PubMed ID: 35141330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance of Signet Ring Cells in Gastric Cancer: The Higher Proportion, The Better Survival.
    Li Y; Zhong Y; Xu Q; Zhu Z; Tian Y
    Front Oncol; 2021; 11():713587. PubMed ID: 34858807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study.
    Wei Q; Gao Y; Qi C; Yuan X; Li J; Xu Q; Luo C; Chen L; Zhuo W; Xu Z; Ying J
    Front Oncol; 2021; 11():580545. PubMed ID: 34490073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difference Between Signet Ring Cell Gastric Cancers and Non-Signet Ring Cell Gastric Cancers: A Systematic Review and Meta-Analysis.
    Zhang C; Liu R; Zhang WH; Chen XZ; Liu K; Yang K; Chen XL; Zhao LY; Chen ZX; Zhou ZG; Hu JK
    Front Oncol; 2021; 11():618477. PubMed ID: 34026606
    [No Abstract]   [Full Text] [Related]  

  • 35. The Clinicopathological Characteristics And Genetic Alterations of Signet-ring Cell Carcinoma in Gastric Cancer.
    Huang KH; Chen MH; Fang WL; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer.
    Kerckhoffs KGP; Liu DHW; Saragoni L; van der Post RS; Langer R; Bencivenga M; Iglesias M; Gallo G; Hewitt LC; Fazzi GE; Vos AM; Renaud F; Yoshikawa T; Oshima T; Tomezzoli A; de Manzoni G; Arai T; Kushima R; Carneiro F; Grabsch HI
    Gastric Cancer; 2020 Sep; 23(5):765-779. PubMed ID: 32488651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMI-adjusted prognosis of signet ring cell carcinoma in patients undergoing radical gastrectomy for gastric adenocarcinoma.
    Wang JB; Lin MQ; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Huang CM
    Asian J Surg; 2021 Jan; 44(1):116-122. PubMed ID: 32467008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.
    Fuchs CS; Doi T; Jang RW; Muro K; Satoh T; Machado M; Sun W; Jalal SI; Shah MA; Metges JP; Garrido M; Golan T; Mandala M; Wainberg ZA; Catenacci DV; Ohtsu A; Shitara K; Geva R; Bleeker J; Ko AH; Ku G; Philip P; Enzinger PC; Bang YJ; Levitan D; Wang J; Rosales M; Dalal RP; Yoon HH
    JAMA Oncol; 2018 May; 4(5):e180013. PubMed ID: 29543932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology.
    Wang Z; Zhang X; Hu J; Zeng W; Zhou Z
    J Visc Surg; 2015 Dec; 152(6):357-61. PubMed ID: 26481069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bariatric surgery discovering unexpected silent gastric cancer: a case report.
    Taher MM; Abdalqader MA; Jahanath S; Nasharuddin NN; Al-Hamdan YNY
    J Surg Case Rep; 2024 Apr; 2024(4):rjae209. PubMed ID: 38681481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.